SEI Investments
NUVB icon

SEI Investments’s Nuvation Bio NUVB Stock Holding History

SEI Investments’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$867K Buy
152,628
+109,425
+253% +$535K ﹤0.01% 2375
2026
Q1 		$185K Sell
43,203
-40,963
-49% -$228K ﹤0.01% 2991
2025
Q4 		$754K Buy
84,166
+69,302
+466% +$429K ﹤0.01% 2316
2025
Q3 		$55K Buy
+14,864
New +$40.5K ﹤0.01% 2771

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

SEI Investments's NUVB Position: Q2 2026 in Review

SEI Investments increased its Nuvation Bio (NUVB) stake by 253% in Q2 2026, buying an estimated $535K and bringing the position to 152,628 shares worth $867K. The position accounts for ﹤0.01% of the portfolio, ranked #2375.

SEI Investments first reported a position in NUVB in Q3 2025 and has held it in 4 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • SEI Investments held 152,628 shares of Nuvation Bio worth $867K as of Q2 2026.
  • SEI Investments bought 109,425 Nuvation Bio shares in Q2 2026, an estimated $535K.
  • Nuvation Bio made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2375 holding.
  • SEI Investments first reported a position in Nuvation Bio in Q3 2025 and has held it in 4 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.